Context: Preeclampsia (PE) is a pregnancy-related disease, and it is a leading cause of maternal and neonatal morbidity and mortality. It is characterized by the new onset of hypertension after 20 weeks of gestation together with signs of organ damage, most commonly the kidneys. The treatment of PE is symptomatic and final intervention requires delivery, regardless of the gestational age of the foetus. Furthermore, PE is a risk factor for developing cardiovascular disease and chronic kidney disease - even many years after the delivery.

Objective: Current research of PE has revealed that detection of podocytes in urine (podocyturia) could be a useful method for both confirmation of PE diagnosis and for the prediction of the severity of the disease.

Conclusion: The main aim of this review is to summarize the current state of available methods for podocyte detection and to discuss their relevance in clinical practice.

Download full-text PDF

Source
http://dx.doi.org/10.1080/1354750X.2017.1405283DOI Listing

Publication Analysis

Top Keywords

podocyturia early
4
early diagnostic
4
diagnostic marker
4
marker preeclampsia
4
preeclampsia literature
4
literature review
4
review context
4
context preeclampsia
4
preeclampsia pregnancy-related
4
pregnancy-related disease
4

Similar Publications

Article Synopsis
  • * The study involved 35 healthy dogs and 37 dogs with leishmaniosis, measuring urinary podocin and nephrin levels using a reliable test and comparing results across different stages of kidney disease according to the International Renal Interest Society guidelines.
  • * Results showed that dogs with leishmaniosis had lower urinary podocin and nephrin levels than healthy dogs, suggesting that as kidney disease progresses (especially in IRIS stages II-IV), these markers decrease, highlighting the importance of monitoring these urinary concentrations
View Article and Find Full Text PDF

Potential urinary biomarkers in preeclampsia: a narrative review.

Mol Biol Rep

January 2024

Liga Acadêmica de Pesquisa Científica, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.

Introduction: Preeclampsia (PE) is a highly relevant pregnancy-related disorder. An early and accurate diagnosis is crucial to prevent major maternal and neonatal complications and mortality. Due to the association of kidney dysfunction with the pathophysiology of the disease, urine samples have the potential to provide biomarkers for PE prediction, being minimally invasive and easy to perform.

View Article and Find Full Text PDF

Background: Fabry disease (FD) is a rare X-linked disorder of sphingolipid metabolism that results in chronic proteinuric nephropathy. Podocytes are one of the most affected renal cells and play an important role in the development and progression of kidney disease. Detached podocytes found in urine (podocyturia) are considered as a non-invasive early marker of kidney injury; however, the dynamics of podocyte loss remains unknown.

View Article and Find Full Text PDF
Article Synopsis
  • * It compares a new liquid chromatography mass spectrometry (LC-MS/MS) technique against the traditional enzyme-linked immunosorbent assay (ELISA) for identifying these biomarkers in urine samples from pregnant women.
  • * Results show that the LC-MS/MS method with peptide charge derivatization successfully identifies podocin earlier in pregnancy than the ELISA test, suggesting a potential breakthrough in medical diagnostics for preeclampsia.
View Article and Find Full Text PDF

Background: Diabetes mellitus (DM) is marked by oxidative stress, inflammation, and vascular dysfunction that caused diabetic nephropathy that resulted in end-stage renal disease (ESRD). Vascular dysfunction is characterized by an imbalance in vasoconstrictor and vasodilator agents which underlies the mechanism of vascular injury in DM. Additionally, diminished podocytes correlate with the severity of kidney injury.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!